Correlation Between Elite Pharma and NewGenIvf Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elite Pharma and NewGenIvf Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elite Pharma and NewGenIvf Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elite Pharma and NewGenIvf Group Limited, you can compare the effects of market volatilities on Elite Pharma and NewGenIvf Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elite Pharma with a short position of NewGenIvf Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elite Pharma and NewGenIvf Group.

Diversification Opportunities for Elite Pharma and NewGenIvf Group

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Elite and NewGenIvf is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Elite Pharma and NewGenIvf Group Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewGenIvf Group and Elite Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elite Pharma are associated (or correlated) with NewGenIvf Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewGenIvf Group has no effect on the direction of Elite Pharma i.e., Elite Pharma and NewGenIvf Group go up and down completely randomly.

Pair Corralation between Elite Pharma and NewGenIvf Group

If you would invest  4.88  in NewGenIvf Group Limited on September 30, 2024 and sell it today you would lose (0.39) from holding NewGenIvf Group Limited or give up 7.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy0.95%
ValuesDaily Returns

Elite Pharma  vs.  NewGenIvf Group Limited

 Performance 
       Timeline  
Elite Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elite Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Elite Pharma is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.
NewGenIvf Group 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in NewGenIvf Group Limited are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical and fundamental indicators, NewGenIvf Group showed solid returns over the last few months and may actually be approaching a breakup point.

Elite Pharma and NewGenIvf Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elite Pharma and NewGenIvf Group

The main advantage of trading using opposite Elite Pharma and NewGenIvf Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elite Pharma position performs unexpectedly, NewGenIvf Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewGenIvf Group will offset losses from the drop in NewGenIvf Group's long position.
The idea behind Elite Pharma and NewGenIvf Group Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device